The past week has been a pretty tough one for Kraig Biocraft Laboratories Inc (OTCMKTS:KBLB) in the markets and during that period the stock has declined by as much as 14%. In light of the drop in the stock price, it is perhaps time for investors to figure out if this could actually be an opportunity to pick up the Kraig Biocraft Laboratories at a discount.
The company, which is one of the major players in the development of fibres from spider silk, announced yesterday that it further consolidates its position in the industry with two fresh patent applications.
The pair of patents are related to the knock in and knock out gene editing technologies that had first been made public by Kraig Biocraft Laboratories back in 2020.
These two technologies are vital to the company since it further expands on the nearly pure spider silk genetic engineering systems. By way of these technologies, the company will be able to come up with bigger, far more complex and varied protein production systems. It goes without saying that the filing of the patents marks an important milestone for Kraig Biocraft Laboratories and despite the drop in the stock price over the past week, it is a stock that could be worth tracking.